Help
RSS
API
Feed
Maltego
Contact
Domain > p2y12-inhibitor-series.com
×
Welcome!
Right click nodes and scroll the mouse to navigate the graph.
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2023-08-26
79.125.82.145
(
ClassC
)
2024-04-22
52.49.100.164
(
ClassC
)
2024-05-18
52.208.28.117
(
ClassC
)
2024-09-08
52.50.143.29
(
ClassC
)
2024-10-06
63.32.32.118
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyServer: awselb/2.0Date: Sat, 26 Aug 2023 14:15:19 GMTContent-Type: text/htmlContent-Length: 134Connection: keep-aliveLocation: https://p2y12-inhibitor-series.com:443/ html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Sat, 26 Aug 2023 14:15:20 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-aliveP3P: CPNOI DSP COR CURa OUR STP STASet-Cookie: _muu5b11e54e-c426- !DOCTYPE html>html langen>head>title>Where Do Potent P2Y12 Inhibitors Fit Into Current Practice? /title>link relshortcut icon hrefhttps://d39ion77s0ucuz.cloudfront.net/a/522585.jpg typeimage/x-icon>meta propertyog:title contentWhere Do Potent P2Y12 Inhibitors Fit Into Current Practice? >meta nametwitter:card contentsummary_large_image>meta nametwitter:title contentWhere Do Potent P2Y12 Inhibitors Fit Into Current Practice? >meta propertyog:image contenthttps://d39ion77s0ucuz.cloudfront.net/a/522588.jpg>meta nametwitter:image contenthttps://d39ion77s0ucuz.cloudfront.net/a/522588.jpg>link relimage_src contenthttps://d39ion77s0ucuz.cloudfront.net/a/522588.jpg>meta propertyog:description contentThis webinar series is supported by an unrestricted educational grant from AstraZeneca>meta namedescription contentThis webinar series is supported by an unrestricted educational grant from AstraZeneca>meta nametwitter:description contentThis webinar series is supported by an unrestricted educational grant from AstraZeneca>meta charsetUTF-8>meta nameviewport contentwidthdevice-width, initial-scale1, maximum-scale1>meta namefacebook-domain-verification contentzt78z9lgsczswlmvh85nlvgyk1b46d />script typetext/javascript>(function() { var didInit false; function initMunchkin() { if(didInit false) { didInit true; Munchkin.init(848-IAM-860); } } var s document.createElement(script); s.type text/javascript; s.async true; s.src //munchkin.marketo.net/munchkin.js; s.onreadystatechange function() { if (this.readyState complete || this.readyState loaded) { initMunchkin(); } }; s.onload initMunchkin; document.getElementsByTagName(head)0.appendChild(s);})();/script>script typetext/javascript>var _im{contentPreloaded:true,host:leadintel.io,ad:2656,site:38,country:US,layout:2167,token:B7C76C76DA5CFE53ED72B76C0C7C787D|1693059320412#604800000};/script>script typetext/javascript src//d39ion77s0ucuz.cloudfront.net/in-microsite/loader.js>/script>script typetext/javascript src//platform.twitter.co
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]